NEW YORK (GenomeWeb) – Since the American College of Medical Genetics first recommended that clinical laboratories search for and report on pathogenic findings in around 56 genes associated with serious genetic conditions, there has been much debate on the impact of doing so. Critics worried that it would be too much of a burden on laboratories, that patients and physicians alike would not know what to make of the findings, and that it would prove too challenging to figure out the meaning of potentially disease-causing variants in individuals who were so far symptom free.

Get the full story with
GenomeWeb Premium

Only $95 for the
first 90 days*

GenomeWeb Premium gives you:
✔ Full site access
✔ Interest-based email alerts
✔ Access to archives

Never miss another important industry story.

Try GenomeWeb Premium now.

You may already have institutional access!

Check if I qualify.

Already a GenomeWeb or 360Dx Premium member?
Login Now.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Register for Free Content
You can still register for access to our free content.